Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

Bibliographic Details
Main Authors:	Schmeling H, Horneff G
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

THE ROLE OF THE SOLUBLE TNF-ALPHA RECEPTORS IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. M. Bzarova, et al.
Published: (2012-07-01)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
by: Bayraktar S, et al.
Published: (2008-09-01)

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review
by: Gerd Horneff, et al.
Published: (2023-02-01)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
by: Kiss EV, et al.
Published: (2011-09-01)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008-09-01)

Expression of tumour necrosis factor alpha (TNF alpha) and lysozyme in necrotizing enterocolitis (NEC)
by: Lala, S, et al.
Published: (2002)

The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
by: Tchorzewski, H, et al.
Published: (1993)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
by: Reima Bakry, et al.
Published: (2022-10-01)

Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
by: Semeraro F, et al.
Published: (2014-03-01)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
by: Cerqueiro C, et al.
Published: (2011-09-01)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
by: Cullen, SN, et al.
Published: (2003)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
by: Gary Brierly, et al.
Published: (2023-03-01)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER
by: Ekaterina I. Alexeeva, et al.
Published: (2017-09-01)

Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis.
by: Williams, R
Published: (2008)

The role of Tumour Necrosis Factor Alpha (TNF-ALPHA) serum level and genetic polymorphisms with cutaneous leishmania infections
by: Eman Salman Khamaes, et al.
Published: (2023-10-01)

Concerted Actions by PIICP, CTXII, and TNF-α in Patients with Juvenile Idiopathic Arthritis
by: Katarzyna Winsz-Szczotka, et al.
Published: (2021-04-01)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
by: Williams, R, et al.
Published: (2000)

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
by: Cristián Navarrete-Dechent, et al.
Published: (2015-06-01)

Differences in pharmacology of tumor necrosis factor (TNF) antagonists
by: S. Bombardieri, et al.
Published: (2011-09-01)

Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011-06-01)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008-09-01)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
by: Tarkiainen M, et al.
Published: (2008-09-01)

EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α
by: Yu. M. Spivakovskii, et al.
Published: (2015-04-01)

Juvenile Idiopathic Arthritis
by: Kenan Barut, et al.
Published: (2017-04-01)

Juvenile Idiopathic Arthritis
by: Aleksandra Strońska, et al.
Published: (2021-08-01)

Juvenile idiopathic arthritis
by: Krupa H Bhatt, et al.
Published: (2014-01-01)

Acceptability of an Adolescent Self‐Management Program for Juvenile Idiopathic Arthritis
by: Kelsey Chomistek, et al.
Published: (2022-02-01)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
by: Feldmann, M
Published: (1996)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012-11-01)

Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.
by: Pau Bosch-Nicolau, et al.
Published: (2019-08-01)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
by: Anton J, et al.
Published: (2011-09-01)

TNF blockade contributes to restore lipid oxidation during exercise in children with juvenile idiopathic arthritis
by: Emmanuelle Rochette, et al.
Published: (2019-07-01)

Treatment of systemic-onset juvenile arthritis with canakinumab
by: Peitz J, et al.
Published: (2015-02-01)

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
by: Mia Lindegaard Pedersen, et al.
Published: (2023-09-01)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)

Haptoglobin in Juvenile Idiopathic Arthritis
by: Lillemor Berntson, et al.
Published: (2022-12-01)

Juvenile Idiopathic Arthritis and Exercise
by: Pınar Kısacık, et al.
Published: (2016-04-01)

Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.
by: Kristensen, M, et al.
Published: (1993)